Veradigm (MDRX) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
23 Jun, 2025Executive summary
Closed over $30 million in annual contract value deals in Q1 2025, a 25% increase year-over-year.
Focused on maintaining momentum and becoming current in SEC filings by 2026.
Financial highlights
Q1 2025 GAAP revenue estimated at $145–$147 million, up slightly from $144–$146 million in Q1 2024.
Cash and equivalents at $272 million as of March 31, 2025, down from $295 million at year-end 2024.
Debt remained at $208 million as of March 31, 2025, all in 0.875% Convertible Senior Notes due 2027.
Net cash expected to remain positive for fiscal 2025.
Outlook and guidance
Fiscal 2025 GAAP revenue expected to be approximately flat versus 2024, estimated at $583–$588 million.
Company reaffirms 2025 guidance and expects to relist common stock after becoming current in SEC filings.
Latest events from Veradigm
- 2025 revenue guidance slightly down, with new strategy, AI, and payer deals supporting growth.MDRX
Status update18 Feb 2026 - Q2 2025 revenue dipped 2%, cash rose to $350M, and major debt repurchases were completed.MDRX
Investor Update22 Dec 2025 - 2024 revenue and EBITDA declined, with internal controls remediation ongoing through 2026.MDRX
Q4 202417 Dec 2025 - Q1 2025 contract value rose 25% year-over-year, with revenue at $145–$147 million and new financing.MDRX
Status Update14 Nov 2025 - Q2 2025 revenue fell 2% year-over-year, but cash rose sharply after major debt repurchases.MDRX
Q2 20252 Oct 2025